ATE239500T1 - Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation - Google Patents

Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation

Info

Publication number
ATE239500T1
ATE239500T1 AT98913813T AT98913813T ATE239500T1 AT E239500 T1 ATE239500 T1 AT E239500T1 AT 98913813 T AT98913813 T AT 98913813T AT 98913813 T AT98913813 T AT 98913813T AT E239500 T1 ATE239500 T1 AT E239500T1
Authority
AT
Austria
Prior art keywords
diuretic
treatment
combination
angiotensing
enzyme inhibitors
Prior art date
Application number
AT98913813T
Other languages
English (en)
Inventor
David Guez
Pierre Schiavi
Bernard Levy
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE239500T1 publication Critical patent/ATE239500T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
AT98913813T 1997-11-19 1998-03-03 Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation ATE239500T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714485A FR2771010B1 (fr) 1997-11-19 1997-11-19 Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
PCT/FR1998/000411 WO1999025374A1 (fr) 1997-11-19 1998-03-03 Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires

Publications (1)

Publication Number Publication Date
ATE239500T1 true ATE239500T1 (de) 2003-05-15

Family

ID=9513523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98913813T ATE239500T1 (de) 1997-11-19 1998-03-03 Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation

Country Status (21)

Country Link
US (1) US6653336B1 (de)
EP (1) EP1032414B1 (de)
JP (1) JP2001523646A (de)
CN (1) CN1227029C (de)
AT (1) ATE239500T1 (de)
AU (1) AU740748B2 (de)
BR (1) BR9814885A (de)
CA (1) CA2310136C (de)
DE (1) DE69814444T2 (de)
DK (1) DK1032414T3 (de)
EA (1) EA002968B1 (de)
ES (1) ES2198708T3 (de)
FR (1) FR2771010B1 (de)
HK (1) HK1033096A1 (de)
HU (1) HU226022B1 (de)
NO (1) NO20002479L (de)
NZ (1) NZ504220A (de)
PL (1) PL340561A1 (de)
PT (1) PT1032414E (de)
WO (1) WO1999025374A1 (de)
ZA (1) ZA986673B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
BRPI0209720A2 (pt) * 2001-05-31 2017-06-13 Microdose Tech Inc dosagem e embalagem de medicação com liberação controlada
US20040156903A1 (en) * 2002-05-22 2004-08-12 Abrams Andrew L.. Metering and packaging of controlled release medication
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril
US20050113314A1 (en) * 2003-08-29 2005-05-26 Fong Benson M. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
CN1292747C (zh) * 2003-09-16 2007-01-03 广东省心血管病研究所 一种用于治疗高血压的复方制剂
HUE031058T2 (en) * 2004-03-29 2017-06-28 Servier Lab A method of producing a solid pharmaceutical composition
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
MY138209A (en) * 2005-03-11 2009-05-29 Servier Lab New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
DE102005058166A1 (de) * 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
WO2008068577A2 (en) * 2006-12-01 2008-06-12 Glenmark Pharmaceuticals Limited Pharmaceutical compositions
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CA3123992A1 (en) 2011-09-29 2013-04-04 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
PT804229E (pt) * 1995-03-16 2003-06-30 Pfizer Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica

Also Published As

Publication number Publication date
CA2310136A1 (fr) 1999-05-27
JP2001523646A (ja) 2001-11-27
EA200000536A1 (ru) 2000-10-30
HU226022B1 (en) 2008-03-28
HUP0004544A2 (hu) 2001-06-28
PL340561A1 (en) 2001-02-12
PT1032414E (pt) 2003-08-29
ES2198708T3 (es) 2004-02-01
AU740748B2 (en) 2001-11-15
DE69814444T2 (de) 2004-03-18
EA002968B1 (ru) 2002-12-26
ZA986673B (en) 1999-02-04
NZ504220A (en) 2003-05-30
NO20002479D0 (no) 2000-05-12
EP1032414B1 (de) 2003-05-07
HUP0004544A3 (en) 2001-07-30
CA2310136C (fr) 2004-04-20
DE69814444D1 (de) 2003-06-12
EP1032414A1 (de) 2000-09-06
DK1032414T3 (da) 2003-09-01
CN1227029C (zh) 2005-11-16
AU6837798A (en) 1999-06-07
FR2771010B1 (fr) 2003-08-15
HK1033096A1 (en) 2001-08-17
NO20002479L (no) 2000-05-12
US6653336B1 (en) 2003-11-25
BR9814885A (pt) 2000-10-03
WO1999025374A1 (fr) 1999-05-27
FR2771010A1 (fr) 1999-05-21
CN1279615A (zh) 2001-01-10

Similar Documents

Publication Publication Date Title
ATE239500T1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
KR950700323A (ko) 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE)
FI962246A0 (fi) Apoptoosia inhiboivat koostumukset, koostumusten puhdistusmenetelmät ja niiden käyttö
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
PT871454E (pt) Inibidores fosforosos que contem protease de cisteina e de serina
DE69835532D1 (de) Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease
DK0885881T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfaminsyrer, der er anvendelige som retrovirale proteaseinhibitorer
HK1025511A1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
DE69835288D1 (de) Kombinationstherapie zur modulation der humanen sexualreaktion
GB2331988B (en) Polycyclic sulphamate inhibitors or oestrone sulphatase
NO911999L (no) Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
TR200000954T2 (tr) Mikrodolaşım hastalıklarının tedavisi ve önlenmesi için madde.
DK1042288T3 (da) Tripeptidyl-peptidase inhibitorer
DE69821228T2 (de) Selektive mmp inhibitoren mit verringerten nebenwirkungen
MY106261A (en) Anti-inflammatory 1-heteroaryl oxindole-3-carboxamides.
DE69227089T2 (de) Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1032414

Country of ref document: EP